Halozyme
HALO
158 hedge funds and large institutions have $2.2B invested in Halozyme in 2015 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 52 increasing their positions, 52 reducing their positions, and 12 closing their positions.
175% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 12
86% more call options, than puts
Call options by funds: $46.6M | Put options by funds: $25.1M
63% more capital invested
Capital invested by funds: $1.35B → $2.2B (+$855M)
15% more funds holding
Funds holding: 137 → 158 (+21)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 52
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$25.6M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$19.4M |
| 3 |
Millennium Management
New York
|
+$13.2M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.1M |
| 5 |
First Eagle Investment Management
New York
|
+$5.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
-$7.47M |
| 2 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
-$6.08M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$5.57M |
| 4 |
JCG
JHL Capital Group
Chicago,
Illinois
|
-$5.36M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$4.4M |
HALO Hedge Fund Activity: Q2 2015 in Review
158 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q2 2015, worth a combined $2.2B — up 63% from $1.35B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new HALO positions and 12 closed out — a net gain of 21 holders — while 52 added to existing stakes and 52 trimmed.
The largest buyer was Iridian Asset Management, adding an estimated $25.6M. The largest seller was VOYA Investment Management, cutting an estimated $7.47M.
- 158 institutional investors held Halozyme (HALO) as of Q2 2015, up from 137 in Q1 2015.
- Funds reported $2.2B of Halozyme stock for Q2 2015, up 63% quarter-over-quarter.
- 33 funds opened new Halozyme positions in Q2 2015 and 12 closed out, a net change of +21 holders.
- The largest Halozyme buyer in Q2 2015 was Iridian Asset Management, an estimated $25.6M added.
- The largest Halozyme seller in Q2 2015 was VOYA Investment Management, an estimated $7.47M sold.
Based on aggregated 13F filings for Q2 2015.